Is Ozempic the same as Wegovy?

Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different.

Can I still get compounded GLP-1 in 2026?

For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested.

Why do GLP-1 medications cost so much in the US?

List prices ($1,100-$1,350/mo) reflect manufacturer pricing, US-specific lack of price negotiation (until IRA implementation), and high R&D recovery on patent. Cash and PAP programs now bring effective prices to $349-$499/mo (NovoCare Pharmacy, Lilly Direct).

BCBS Federal Employee Program appeal guide

BCBS Federal Employee Program Ozempic coverage appeal

BCBS Federal Employee Program uses specific clinical-policy criteria for Ozempic. Most denials come from undocumented BMI history or missing step-therapy notes. Here is how to address both.

BCBS Federal Employee Program prior authorization criteria for Ozempic

BMI ≥30 (or ≥27 + comorbidity)
PA submitted via CVS Caremark portal

BCBS Federal Employee Program Ozempic policy bulletin

Step-by-step appeal flow

1
Pull your carrier policy bulletin
BCBS Federal Employee Program publishes its Ozempic coverage criteria. Read it first — every successful appeal cites it back to the reviewer.
2
Document your medical necessity
BMI ≥30 (or ≥27 + comorbidity) PA submitted via CVS Caremark portal
3
Have your prescriber submit the PA
Most BCBS Federal Employee Program PAs go through CoverMyMeds or the carrier portal. Your prescriber attaches BMI history, comorbidities (with ICD-10 codes), lifestyle program participation, and prior weight-loss attempts.
4
If denied — file the appeal within 60 days
Federal BCBS uses CVS Caremark for pharmacy benefits — appeal goes through Caremark portal, not BCBS directly. Use Caremark-specific appeal forms.
5
Submit external review if internal appeals fail
After two internal appeals, you can request external review through your state insurance commissioner. ERISA plans go through the federal external-review process.

Letter template

Customizable BCBS Federal Employee Program appeal letter

We provide a generic medical-necessity letter generator. Customize with the BCBS Federal Employee Program-specific framing above for highest first-pass success.

Generate appeal letter

Common questions readers ask

Is Ozempic the same as Wegovy?: Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different.
Can I still get compounded GLP-1 in 2026?: For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested.
Why do GLP-1 medications cost so much in the US?: List prices ($1,100-$1,350/mo) reflect manufacturer pricing, US-specific lack of price negotiation (until IRA implementation), and high R&D recovery on patent. Cash and PAP programs now bring effective prices to $349-$499/mo (NovoCare Pharmacy, Lilly Direct).

Editorial information based on published BCBS Federal Employee Program coverage policies as of 2026. Your specific plan benefits may differ — confirm with your insurance card’s member services number. Not legal advice.